OnKure Therapeutics

0 followers


OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.

Employees

11-50

Links

Org chart

Anthony D. Piscopio
CEO & President

Anthony D. Piscopio

Collapse
Jim Winkler
Scientific Advisor
Jennifer Diamond
Chief Medical Officer
Duncan Walker
Chief Development Officer
James Blake
SVP, Computational Drug Discovery
Mark L. Boys
VP, Discovery Chemistry
Ann Howell
VP, Regulatory Affairs
Duncan W.
Chief Development Officer (cdo)
Samuel Agresta
Chief Medical Officer